Systems Medicine LLC Report issue

For profit Phase 2
Founded: Tucson AZ United States (2007)
Status: Acquired by CTI BioPharma (2007) → now Advent International (2021)

Organization Overview

First Clinical Trial
2007
NCT00633165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

brostallicin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liposarcoma (Phase 2)

Liposarcoma, Myxoid (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1